









Markets
/
Stocks
/
nasdaq-sny
/

Sanofi SA

SNY

View Detailed Chart

49.670USD

-1.160-2.28%

Close 06/13, 16:00（ET）Quotes delayed by 15 min

124.53BMarket Cap

20.57P/E TTM



Sanofi SA

49.670

-1.160-2.28%

Company

Intraday

30m

Today

-2.28%

5 Days

-1.59%

1 Month

+0.93%

6 Months

+6.13%

Year to Date

+2.99%

1 Year

+7.39%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 9 analysts

BUY

Current Rating

66.456

Target Price

33.80%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

167

Total

Median

Average

Company name

Ratings

Analysts

Sanofi SA

SNY

Biogen Inc

BIIB

Vertex Pharmaceuticals Inc

VRTX

Alnylam Pharmaceuticals Inc

ALNY

Amgen Inc

AMGN

Gilead Sciences Inc

GILD

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(9)

Neutral(4)

Buy(0)

Indicators

Sell(3)

Neutral(4)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

0.021

Neutral

RSI(14)

43.170

Neutral

STOCH(KDJ)(9,3,3)

54.638

Neutral

ATR(14)

0.984

Low Volatility

CCI(14)

-38.604

Neutral

Williams %R

75.591

Sell

TRIX(12,20)

-0.202

Sell

StochRSI(14)

17.814

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

49.966

Sell

MA10

49.794

Sell

MA20

50.914

Sell

MA50

51.551

Sell

MA100

53.406

Sell

MA200

52.821

Sell

News

More news coming soon, stay tuned...

Company

Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Ticker SymbolSNY

CompanySanofi SA

CEOMr. Paul Hudson, Ph.D.

Websitehttps://www.sanofi.com/